This Week in Nature

In Nature Biotechnology this week, a group led by Foundation Medicine researchers report on a clinical cancer genomic profiling test that uses massively parallel DNA sequencing to help improve patient diagnosis. Using the sequencing technology, they characterized base substitutions, short insertions and deletions, copy number alterations, and selected fusions across 287 cancer-related genes from routine formalin-fixed and paraffin-embedded clinical specimens.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.